Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Inventory (2016 - 2019)

Aptevo Therapeutics' Inventory history spans 5 years, with the latest figure at $6.1 million for Q4 2019.

  • For Q4 2019, Inventory rose 243.92% year-over-year to $6.1 million; the TTM value through Dec 2019 reached $6.1 million, up 243.92%, while the annual FY2019 figure was $6.1 million, 243.92% up from the prior year.
  • Inventory for Q4 2019 was $6.1 million at Aptevo Therapeutics, down from $7.5 million in the prior quarter.
  • Across five years, Inventory topped out at $20.3 million in Q4 2015 and bottomed at $461000.0 in Q4 2016.
  • The 5-year median for Inventory is $5.2 million (2019), against an average of $6.6 million.
  • The largest annual shift saw Inventory plummeted 97.73% in 2016 before it surged 243.92% in 2019.
  • A 5-year view of Inventory shows it stood at $20.3 million in 2015, then tumbled by 97.73% to $461000.0 in 2016, then skyrocketed by 122.99% to $1.0 million in 2017, then soared by 73.64% to $1.8 million in 2018, then soared by 243.92% to $6.1 million in 2019.
  • Per Business Quant, the three most recent readings for APVO's Inventory are $6.1 million (Q4 2019), $7.5 million (Q3 2019), and $7.0 million (Q2 2019).